BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ward-Hartstonge KA, Kemp RA. Regulatory T-cell heterogeneity and the cancer immune response. Clin Transl Immunology. 2017;6:e154. [PMID: 28983402 DOI: 10.1038/cti.2017.43] [Cited by in Crossref: 76] [Cited by in F6Publishing: 82] [Article Influence: 12.7] [Reference Citation Analysis]
Number Citing Articles
1 Vladimirova LY, Teplyakova MA, Popova IL, Abramova NA, Tikhanovskaya NM, Lianova AA, Storozhakova AE, Ryadinskaya LA, Kabanov SN, Kalabanova EA, Udalenkova IA, Trifanov D. Modern aspects of immunotherapy with checkpoint inhibitors in melanoma. Medicinskij alfavit 2022. [DOI: 10.33667/2078-5631-2022-26-35-40] [Reference Citation Analysis]
2 Li W, An N, Wang M, Liu X, Mei Z. Interleukin-23 receptor defines T helper 1-like regulatory T cells in oral squamous cell carcinoma. Immun Inflamm Dis 2022;10:e746. [PMID: 36444617 DOI: 10.1002/iid3.746] [Reference Citation Analysis]
3 Hasan S, Awasthi P, Malik S, Dwivedi M. Immunotherapeutic strategies to induce inflection in the immune response: therapy for cancer and COVID-19. Biotechnology and Genetic Engineering Reviews 2022. [DOI: 10.1080/02648725.2022.2147661] [Reference Citation Analysis]
4 Su X, Sun T, Li M, Xia Y, Li M, Wang D, Lu F, Ye J, Ji C. Lkb1 aggravates diffuse large B-cell lymphoma by promoting the function of Treg cells and immune escape. J Transl Med 2022;20. [DOI: 10.1186/s12967-022-03588-0] [Reference Citation Analysis]
5 Urbiola-salvador V, Miroszewska D, Jabłońska A, Qureshi T, Chen Z. Proteomics approaches to characterize the immune responses in cancer. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2022;1869:119266. [DOI: 10.1016/j.bbamcr.2022.119266] [Reference Citation Analysis]
6 Tan JY, Low MH, Chen Y, Lim FLWI. CAR T Cell Therapy in Hematological Malignancies: Implications of the Tumor Microenvironment and Biomarkers on Efficacy and Toxicity. IJMS 2022;23:6931. [DOI: 10.3390/ijms23136931] [Reference Citation Analysis]
7 Jin L, Tang B, Liu X, Mao W, Xia L, Du Y, Ji B, Shou Q, Fu H, Wang K. Blood Stasis Syndrome Accelerates the Growth and Metastasis of Breast Cancer by Promoting Hypoxia and Immunosuppressive Microenvironment in Mice. Journal of Immunology Research 2022;2022:1-12. [DOI: 10.1155/2022/7222638] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Amarillo D, Brugnini A, Trías N, Rodriguez Sande V, Salisbury S, Cuello M, Lens D. Circulating T regulatory cell subsets in patients with untreated lung cancer. Clin Transl Oncol 2022. [PMID: 35445283 DOI: 10.1007/s12094-022-02827-6] [Reference Citation Analysis]
9 Arai J, Niikura R, Hayakawa Y, Suzuki N, Hirata Y, Ushiku T, Fujishiro M. Clinicopathological Features of Gastric Cancer with Autoimmune Gastritis. Biomedicines 2022;10:884. [DOI: 10.3390/biomedicines10040884] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tiwari JK, Negi S, Kashyap M, Nizamuddin S, Singh A, Khattri A. Pan-Cancer Analysis Shows Enrichment of Macrophages, Overexpression of Checkpoint Molecules, Inhibitory Cytokines, and Immune Exhaustion Signatures in EMT-High Tumors. Front Oncol 2021;11:793881. [PMID: 35096592 DOI: 10.3389/fonc.2021.793881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Mirzaei R, Sabokroo N, Ahmadyousefi Y, Motamedi H, Karampoor S. Immunometabolism in biofilm infection: lessons from cancer. Mol Med 2022;28. [DOI: 10.1186/s10020-022-00435-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
12 Mahalanobis S, Apoorva, Sharma N, Luthra R, Menon T, Das A. Cancer prognosis and immune system. Microbial Crosstalk with Immune System 2022. [DOI: 10.1016/b978-0-323-96128-8.00004-3] [Reference Citation Analysis]
13 Unver N, Mohindroo C. Targets and Strategies for Cancer Immunoprevention. Methods in Molecular Biology 2022. [DOI: 10.1007/978-1-0716-2014-4_2] [Reference Citation Analysis]
14 Cordero OJ, Varela-calviño R, Graña-suárez B, García-lópez A. Immunology and immunotherapy in CRC. Foundations of Colorectal Cancer 2022. [DOI: 10.1016/b978-0-323-90055-3.00031-4] [Reference Citation Analysis]
15 Cossarizza A, Chang HD, Radbruch A, Abrignani S, Addo R, Akdis M, Andrä I, Andreata F, Annunziato F, Arranz E, Bacher P, Bari S, Barnaba V, Barros-Martins J, Baumjohann D, Beccaria CG, Bernardo D, Boardman DA, Borger J, Böttcher C, Brockmann L, Burns M, Busch DH, Cameron G, Cammarata I, Cassotta A, Chang Y, Chirdo FG, Christakou E, Čičin-Šain L, Cook L, Corbett AJ, Cornelis R, Cosmi L, Davey MS, De Biasi S, De Simone G, Del Zotto G, Delacher M, Di Rosa F, Santo JD, Diefenbach A, Dong J, Dörner T, Dress RJ, Dutertre CA, Eckle SBG, Eede P, Evrard M, Falk CS, Feuerer M, Fillatreau S, Fiz-Lopez A, Follo M, Foulds GA, Fröbel J, Gagliani N, Galletti G, Gangaev A, Garbi N, Garrote JA, Geginat J, Gherardin NA, Gibellini L, Ginhoux F, Godfrey DI, Gruarin P, Haftmann C, Hansmann L, Harpur CM, Hayday AC, Heine G, Hernández DC, Herrmann M, Hoelsken O, Huang Q, Huber S, Huber JE, Huehn J, Hundemer M, Hwang WYK, Iannacone M, Ivison SM, Jäck HM, Jani PK, Keller B, Kessler N, Ketelaars S, Knop L, Knopf J, Koay HF, Kobow K, Kriegsmann K, Kristyanto H, Krueger A, Kuehne JF, Kunze-Schumacher H, Kvistborg P, Kwok I, Latorre D, Lenz D, Levings MK, Lino AC, Liotta F, Long HM, Lugli E, MacDonald KN, Maggi L, Maini MK, Mair F, Manta C, Manz RA, Mashreghi MF, Mazzoni A, McCluskey J, Mei HE, Melchers F, Melzer S, Mielenz D, Monin L, Moretta L, Multhoff G, Muñoz LE, Muñoz-Ruiz M, Muscate F, Natalini A, Neumann K, Ng LG, Niedobitek A, Niemz J, Almeida LN, Notarbartolo S, Ostendorf L, Pallett LJ, Patel AA, Percin GI, Peruzzi G, Pinti M, Pockley AG, Pracht K, Prinz I, Pujol-Autonell I, Pulvirenti N, Quatrini L, Quinn KM, Radbruch H, Rhys H, Rodrigo MB, Romagnani C, Saggau C, Sakaguchi S, Sallusto F, Sanderink L, Sandrock I, Schauer C, Scheffold A, Scherer HU, Schiemann M, Schildberg FA, Schober K, Schoen J, Schuh W, Schüler T, Schulz AR, Schulz S, Schulze J, Simonetti S, Singh J, Sitnik KM, Stark R, Starossom S, Stehle C, Szelinski F, Tan L, Tarnok A, Tornack J, Tree TIM, van Beek JJP, van de Veen W, van Gisbergen K, Vasco C, Verheyden NA, von Borstel A, Ward-Hartstonge KA, Warnatz K, Waskow C, Wiedemann A, Wilharm A, Wing J, Wirz O, Wittner J, Yang JHM, Yang J. Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition). Eur J Immunol 2021;51:2708-3145. [PMID: 34910301 DOI: 10.1002/eji.202170126] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 29.5] [Reference Citation Analysis]
16 Wang J, Liu J, Gao L, Li G, Sun Y, Shi B. Heart Rate Variability is an Independent Predictor of Lymph Node Metastasis in Patients with Cervical Cancer. Cancer Manag Res 2021;13:8821-30. [PMID: 34853536 DOI: 10.2147/CMAR.S336268] [Reference Citation Analysis]
17 Tarantelli C, Argnani L, Zinzani PL, Bertoni F. PI3Kδ Inhibitors as Immunomodulatory Agents for the Treatment of Lymphoma Patients. Cancers (Basel) 2021;13:5535. [PMID: 34771694 DOI: 10.3390/cancers13215535] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
18 Hu J, Zhang J, Yu M, Liu Z, Zou Y, Hong L, Zhang T, Sun J, Zheng M, Zhu X, Wang Z, Liu S. Circulating miR-221/222 reduces CD4+ T cells by inhibiting CD4 expression in colorectal cancer. Acta Biochim Biophys Sin (Shanghai) 2021;53:1367-76. [PMID: 34357372 DOI: 10.1093/abbs/gmab106] [Reference Citation Analysis]
19 Chanda M, Cohen MS. Advances in the discovery and development of melanoma drug therapies. Expert Opin Drug Discov 2021;:1-29. [PMID: 34157926 DOI: 10.1080/17460441.2021.1942834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Zhang C, Dang D, Cong L, Sun H, Cong X. Pivotal factors associated with the immunosuppressive tumor microenvironment and melanoma metastasis. Cancer Med 2021;10:4710-20. [PMID: 34159752 DOI: 10.1002/cam4.3963] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
21 Fantini MC, Guadagni I. From inflammation to colitis-associated colorectal cancer in inflammatory bowel disease: Pathogenesis and impact of current therapies. Dig Liver Dis 2021;53:558-65. [PMID: 33541800 DOI: 10.1016/j.dld.2021.01.012] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
22 Jia S, Hu P. ChrNet: A re-trainable chromosome-based 1D convolutional neural network for predicting immune cell types. Genomics 2021;113:2023-31. [PMID: 33932523 DOI: 10.1016/j.ygeno.2021.04.037] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Liu W, Sun L, Zhang J, Song W, Li M, Wang H. The landscape and prognostic value of immune characteristics in uterine corpus endometrial cancer. Biosci Rep 2021;41:BSR20202321. [PMID: 33782686 DOI: 10.1042/BSR20202321] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
24 Cha S, Sin MJ, Kim MJ, Kim HJ, Kim YS, Choi EK, Kim MY. Involvement of Cellular Prion Protein in Invasion and Metastasis of Lung Cancer by Inducing Treg Cell Development. Biomolecules 2021;11:285. [PMID: 33671884 DOI: 10.3390/biom11020285] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
25 Lindo L, Wilkinson LH, Hay KA. Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy. Front Immunol 2020;11:618387. [PMID: 33643299 DOI: 10.3389/fimmu.2020.618387] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
26 Ren M, Zhang S, Zhang Q, Ma S. Gaussian graphical model-based heterogeneity analysis via penalized fusion. Biometrics 2021. [PMID: 33501648 DOI: 10.1111/biom.13426] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
27 Cui L, Wang X, Zhang D. TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer. Front Cell Dev Biol 2020;8:611444. [PMID: 33469538 DOI: 10.3389/fcell.2020.611444] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
28 Wang X, Xiao Z, Gong J, Liu Z, Zhang M, Zhang Z. A prognostic nomogram for lung adenocarcinoma based on immune-infiltrating Treg-related genes: from bench to bedside. Transl Lung Cancer Res 2021;10:167-82. [PMID: 33569302 DOI: 10.21037/tlcr-20-822] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
29 Kleynhans L, Walzl G. Targeting Suppressor T Cells. Advances in Host-Directed Therapies Against Tuberculosis 2021. [DOI: 10.1007/978-3-030-56905-1_12] [Reference Citation Analysis]
30 Fajardo-orduña G, Chamorro-plata D. Molecular and therapeutic bases of cancer. Oncological Functional Nutrition 2021. [DOI: 10.1016/b978-0-12-819828-5.00002-4] [Reference Citation Analysis]
31 Sarangi SC, Sopory P, Pattnaik SS, Reeta KH. Antibody-drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management. Indian J Pharmacol 2020;52:402-13. [PMID: 33283772 DOI: 10.4103/ijp.IJP_475_18] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
32 Ariafar A, Vahidi Y, Fakhimi M, Asadollahpour A, Erfani N, Faghih Z. Prognostic significance of CD4-positive regulatory T cells in tumor draining lymph nodes from patients with bladder cancer. Heliyon 2020;6:e05556. [PMID: 33305045 DOI: 10.1016/j.heliyon.2020.e05556] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
33 Oshi M, Asaoka M, Tokumaru Y, Angarita FA, Yan L, Matsuyama R, Zsiros E, Ishikawa T, Endo I, Takabe K. Abundance of Regulatory T Cell (Treg) as a Predictive Biomarker for Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer. Cancers (Basel) 2020;12:E3038. [PMID: 33086518 DOI: 10.3390/cancers12103038] [Cited by in Crossref: 26] [Cited by in F6Publishing: 29] [Article Influence: 8.7] [Reference Citation Analysis]
34 Linares-Galiana I, Berenguer-Frances MA, Cañas-Cortés R, Pujol-Canadell M, Comas-Antón S, Martínez E, Laplana M, Pérez-Montero H, Pla-Farnós MJ, Navarro-Martin A, Nuñez M, Both B, Guedea F. Changes in peripheral immune cells after intraoperative radiation therapy in low-risk breast cancer. J Radiat Res 2021;62:110-8. [PMID: 33006364 DOI: 10.1093/jrr/rraa083] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
35 Chang C, Chen YP, Medeiros LJ, Chen TY, Chang KC. Higher infiltration of intratumoral CD25+ FOXP3+ lymphocytes correlates with a favorable prognosis in patients with diffuse large B-cell lymphoma. Leuk Lymphoma 2021;62:76-85. [PMID: 32962457 DOI: 10.1080/10428194.2020.1817438] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
36 Fantini MC, Favale A, Onali S, Facciotti F. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf. Int J Mol Sci 2020;21:E6744. [PMID: 32937953 DOI: 10.3390/ijms21186744] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
37 Maibach F, Sadozai H, Seyed Jafari SM, Hunger RE, Schenk M. Tumor-Infiltrating Lymphocytes and Their Prognostic Value in Cutaneous Melanoma. Front Immunol 2020;11:2105. [PMID: 33013886 DOI: 10.3389/fimmu.2020.02105] [Cited by in Crossref: 69] [Cited by in F6Publishing: 75] [Article Influence: 23.0] [Reference Citation Analysis]
38 Mager LF, Burkhard R, Pett N, Cooke NCA, Brown K, Ramay H, Paik S, Stagg J, Groves RA, Gallo M, Lewis IA, Geuking MB, McCoy KD. Microbiome-derived inosine modulates response to checkpoint inhibitor immunotherapy.Science. 2020;369:1481-1489. [PMID: 32792462 DOI: 10.1126/science.abc3421] [Cited by in Crossref: 303] [Cited by in F6Publishing: 301] [Article Influence: 101.0] [Reference Citation Analysis]
39 Neumann S, M. Peyroux E, J. Woodall M, J. Shields N, L. Young S, T. Pattison S. The Influence of Microbial Metabolites in the Gastrointestinal Microenvironment on Anticancer Immunity. Current Cancer Treatment 2020. [DOI: 10.5772/intechopen.88137] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
40 Xie M, Wei J, Xu J. Inducers, Attractors and Modulators of CD4+ Treg Cells in Non-Small-Cell Lung Cancer. Front Immunol 2020;11:676. [PMID: 32425930 DOI: 10.3389/fimmu.2020.00676] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
41 Fedele V, Melisi D. Permissive State of EMT: The Role of Immune Cell Compartment. Front Oncol 2020;10:587. [PMID: 32391271 DOI: 10.3389/fonc.2020.00587] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
42 Petrova V, Arkhypov I, Weber R, Groth C, Altevogt P, Utikal J, Umansky V. Modern Aspects of Immunotherapy with Checkpoint Inhibitors in Melanoma. Int J Mol Sci 2020;21:E2367. [PMID: 32235439 DOI: 10.3390/ijms21072367] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
43 Bhargava A, Mishra DK, Tiwari R, Lohiya NK, Goryacheva IY, Mishra PK. Immune cell engineering: opportunities in lung cancer therapeutics. Drug Deliv Transl Res 2020;10:1203-27. [PMID: 32172351 DOI: 10.1007/s13346-020-00719-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Take Y, Koizumi S, Nagahisa A. Prostaglandin E Receptor 4 Antagonist in Cancer Immunotherapy: Mechanisms of Action. Front Immunol 2020;11:324. [PMID: 32210957 DOI: 10.3389/fimmu.2020.00324] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
45 Picard E, Verschoor CP, Ma GW, Pawelec G. Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer. Front Immunol 2020;11:369. [PMID: 32210966 DOI: 10.3389/fimmu.2020.00369] [Cited by in Crossref: 130] [Cited by in F6Publishing: 143] [Article Influence: 43.3] [Reference Citation Analysis]
46 Petrova V, Arkhypov I, Weber R, Groth C, Altevogt P, Utikal J, Umansky V. Moderne Aspekte der Immuntherapie mit Checkpoint-Inhibitoren bei Melanom. Kompass Dermatol 2020;8:92-101. [DOI: 10.1159/000509449] [Reference Citation Analysis]
47 Cordero OJ, Varela-calviño R, Graña-suárez B. Immunology and Immunotherapy of Colorectal Cancer. Cancer Immunology 2020. [DOI: 10.1007/978-3-030-57949-4_10] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
48 Majumdar S, Saha S. Systems Immunology Approach in Understanding the Association of Allergy and Cancer. Systems and Synthetic Immunology 2020. [DOI: 10.1007/978-981-15-3350-1_2] [Reference Citation Analysis]
49 Cossarizza A, Chang HD, Radbruch A, Acs A, Adam D, Adam-Klages S, Agace WW, Aghaeepour N, Akdis M, Allez M, Almeida LN, Alvisi G, Anderson G, Andrä I, Annunziato F, Anselmo A, Bacher P, Baldari CT, Bari S, Barnaba V, Barros-Martins J, Battistini L, Bauer W, Baumgart S, Baumgarth N, Baumjohann D, Baying B, Bebawy M, Becher B, Beisker W, Benes V, Beyaert R, Blanco A, Boardman DA, Bogdan C, Borger JG, Borsellino G, Boulais PE, Bradford JA, Brenner D, Brinkman RR, Brooks AES, Busch DH, Büscher M, Bushnell TP, Calzetti F, Cameron G, Cammarata I, Cao X, Cardell SL, Casola S, Cassatella MA, Cavani A, Celada A, Chatenoud L, Chattopadhyay PK, Chow S, Christakou E, Čičin-Šain L, Clerici M, Colombo FS, Cook L, Cooke A, Cooper AM, Corbett AJ, Cosma A, Cosmi L, Coulie PG, Cumano A, Cvetkovic L, Dang VD, Dang-Heine C, Davey MS, Davies D, De Biasi S, Del Zotto G, Dela Cruz GV, Delacher M, Della Bella S, Dellabona P, Deniz G, Dessing M, Di Santo JP, Diefenbach A, Dieli F, Dolf A, Dörner T, Dress RJ, Dudziak D, Dustin M, Dutertre CA, Ebner F, Eckle SBG, Edinger M, Eede P, Ehrhardt GRA, Eich M, Engel P, Engelhardt B, Erdei A, Esser C, Everts B, Evrard M, Falk CS, Fehniger TA, Felipo-Benavent M, Ferry H, Feuerer M, Filby A, Filkor K, Fillatreau S, Follo M, Förster I, Foster J, Foulds GA, Frehse B, Frenette PS, Frischbutter S, Fritzsche W, Galbraith DW, Gangaev A, Garbi N, Gaudilliere B, Gazzinelli RT, Geginat J, Gerner W, Gherardin NA, Ghoreschi K, Gibellini L, Ginhoux F, Goda K, Godfrey DI, Goettlinger C, González-Navajas JM, Goodyear CS, Gori A, Grogan JL, Grummitt D, Grützkau A, Haftmann C, Hahn J, Hammad H, Hämmerling G, Hansmann L, Hansson G, Harpur CM, Hartmann S, Hauser A, Hauser AE, Haviland DL, Hedley D, Hernández DC, Herrera G, Herrmann M, Hess C, Höfer T, Hoffmann P, Hogquist K, Holland T, Höllt T, Holmdahl R, Hombrink P, Houston JP, Hoyer BF, Huang B, Huang FP, Huber JE, Huehn J, Hundemer M, Hunter CA, Hwang WYK, Iannone A, Ingelfinger F, Ivison SM, Jäck HM, Jani PK, Jávega B, Jonjic S, Kaiser T, Kalina T, Kamradt T, Kaufmann SHE, Keller B, Ketelaars SLC, Khalilnezhad A, Khan S, Kisielow J, Klenerman P, Knopf J, Koay HF, Kobow K, Kolls JK, Kong WT, Kopf M, Korn T, Kriegsmann K, Kristyanto H, Kroneis T, Krueger A, Kühne J, Kukat C, Kunkel D, Kunze-Schumacher H, Kurosaki T, Kurts C, Kvistborg P, Kwok I, Landry J, Lantz O, Lanuti P, LaRosa F, Lehuen A, LeibundGut-Landmann S, Leipold MD, Leung LYT, Levings MK, Lino AC, Liotta F, Litwin V, Liu Y, Ljunggren HG, Lohoff M, Lombardi G, Lopez L, López-Botet M, Lovett-Racke AE, Lubberts E, Luche H, Ludewig B, Lugli E, Lunemann S, Maecker HT, Maggi L, Maguire O, Mair F, Mair KH, Mantovani A, Manz RA, Marshall AJ, Martínez-Romero A, Martrus G, Marventano I, Maslinski W, Matarese G, Mattioli AV, Maueröder C, Mazzoni A, McCluskey J, McGrath M, McGuire HM, McInnes IB, Mei HE, Melchers F, Melzer S, Mielenz D, Miller SD, Mills KHG, Minderman H, Mjösberg J, Moore J, Moran B, Moretta L, Mosmann TR, Müller S, Multhoff G, Muñoz LE, Münz C, Nakayama T, Nasi M, Neumann K, Ng LG, Niedobitek A, Nourshargh S, Núñez G, O'Connor JE, Ochel A, Oja A, Ordonez D, Orfao A, Orlowski-Oliver E, Ouyang W, Oxenius A, Palankar R, Panse I, Pattanapanyasat K, Paulsen M, Pavlinic D, Penter L, Peterson P, Peth C, Petriz J, Piancone F, Pickl WF, Piconese S, Pinti M, Pockley AG, Podolska MJ, Poon Z, Pracht K, Prinz I, Pucillo CEM, Quataert SA, Quatrini L, Quinn KM, Radbruch H, Radstake TRDJ, Rahmig S, Rahn HP, Rajwa B, Ravichandran G, Raz Y, Rebhahn JA, Recktenwald D, Reimer D, Reis e Sousa C, Remmerswaal EBM, Richter L, Rico LG, Riddell A, Rieger AM, Robinson JP, Romagnani C, Rubartelli A, Ruland J, Saalmüller A, Saeys Y, Saito T, Sakaguchi S, Sala-de-Oyanguren F, Samstag Y, Sanderson S, Sandrock I, Santoni A, Sanz RB, Saresella M, Sautes-Fridman C, Sawitzki B, Schadt L, Scheffold A, Scherer HU, Schiemann M, Schildberg FA, Schimisky E, Schlitzer A, Schlosser J, Schmid S, Schmitt S, Schober K, Schraivogel D, Schuh W, Schüler T, Schulte R, Schulz AR, Schulz SR, Scottá C, Scott-Algara D, Sester DP, Shankey TV, Silva-Santos B, Simon AK, Sitnik KM, Sozzani S, Speiser DE, Spidlen J, Stahlberg A, Stall AM, Stanley N, Stark R, Stehle C, Steinmetz T, Stockinger H, Takahama Y, Takeda K, Tan L, Tárnok A, Tiegs G, Toldi G, Tornack J, Traggiai E, Trebak M, Tree TIM, Trotter J, Trowsdale J, Tsoumakidou M, Ulrich H, Urbanczyk S, van de Veen W, van den Broek M, van der Pol E, Van Gassen S, Van Isterdael G, van Lier RAW, Veldhoen M, Vento-Asturias S, Vieira P, Voehringer D, Volk HD, von Borstel A, von Volkmann K, Waisman A, Walker RV, Wallace PK, Wang SA, Wang XM, Ward MD, Ward-Hartstonge KA, Warnatz K, Warnes G, Warth S, Waskow C, Watson JV, Watzl C, Wegener L, Weisenburger T, Wiedemann A, Wienands J, Wilharm A, Wilkinson RJ, Willimsky G, Wing JB, Winkelmann R, Winkler TH, Wirz OF, Wong A, Wurst P, Yang JHM, Yang J, Yazdanbakhsh M, Yu L, Yue A, Zhang H, Zhao Y, Ziegler SM, Zielinski C, Zimmermann J, Zychlinsky A. Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition). Eur J Immunol 2019;49:1457-973. [PMID: 31633216 DOI: 10.1002/eji.201970107] [Cited by in Crossref: 592] [Cited by in F6Publishing: 604] [Article Influence: 148.0] [Reference Citation Analysis]
50 Kanjana K, Paisooksantivatana K, Matangkasombut P, Chevaisrakul P, Lumjiaktase P. Efficient short-term expansion of human peripheral blood regulatory T cells for co-culture suppression assay. J Immunoassay Immunochem 2019;40:573-89. [PMID: 31460830 DOI: 10.1080/15321819.2019.1659813] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
51 Coventry BJ. Therapeutic vaccination immunomodulation: forming the basis of all cancer immunotherapy. Ther Adv Vaccines Immunother 2019;7:2515135519862234. [PMID: 31414074 DOI: 10.1177/2515135519862234] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
52 Alasiri A, Abboud Guerr J, Hall WW, Sheehy N. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle. J Virol 2019;93:e00412-19. [PMID: 31142665 DOI: 10.1128/JVI.00412-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
53 Bencsikova B, Budinska E, Selingerova I, Pilatova K, Fedorova L, Greplova K, Nenutil R, Valik D, Obermannova R, Sheard MA, Zdrazilova-Dubska L. Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness. BMC Cancer 2019;19:687. [PMID: 31307428 DOI: 10.1186/s12885-019-5909-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
54 Adil AAM, Bommanabonia AK, Vaithy A, Kumar S, Waseem M, Jamal S, Ahmed N. Differential expression of Helios, Neuropilin-1 and FoxP3 in head and neck squamous cell carcinoma (HNSCC) patients. 3 Biotech 2019;9:178. [PMID: 30997315 DOI: 10.1007/s13205-019-1707-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
55 Zhang L, Wang XI, Ding J, Sun Q, Zhang S. The predictive and prognostic value of Foxp3+/CD25+ regulatory T cells and PD-L1 expression in triple negative breast cancer. Ann Diagn Pathol. 2019;40:143-151. [PMID: 31096176 DOI: 10.1016/j.anndiagpath.2019.04.004] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
56 Focaccetti C, Izzi V, Benvenuto M, Fazi S, Ciuffa S, Giganti MG, Potenza V, Manzari V, Modesti A, Bei R. Polyphenols as Immunomodulatory Compounds in the Tumor Microenvironment: Friends or Foes? Int J Mol Sci 2019;20:E1714. [PMID: 30959898 DOI: 10.3390/ijms20071714] [Cited by in Crossref: 35] [Cited by in F6Publishing: 37] [Article Influence: 8.8] [Reference Citation Analysis]
57 Zhou C, Zhang J. Immunotherapy-based combination strategies for treatment of gastrointestinal cancers: current status and future prospects. Front Med 2019;13:12-23. [PMID: 30796606 DOI: 10.1007/s11684-019-0685-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
58 Norton SE, Ward-hartstonge KA, Mccall JL, Leman JKH, Taylor ES, Munro F, Black MA, Fazekas de St. Groth B, Mcguire HM, Kemp RA. High-Dimensional Mass Cytometric Analysis Reveals an Increase in Effector Regulatory T Cells as a Distinguishing Feature of Colorectal Tumors. J I 2019;202:1871-84. [DOI: 10.4049/jimmunol.1801368] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
59 Liu X, Wang X, Ding J, Gao Y, Zhao Y, Zhao R, Sun Q, Zhang S. FOXP3 and CD25 double staining antibody cocktails identify regulatory T cells in different types of tumor tissues using tissue microarrays. Annals of Diagnostic Pathology 2019;38:67-70. [DOI: 10.1016/j.anndiagpath.2018.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
60 Gunda V, Gigliotti B, Ashry T, Ndishabandi D, McCarthy M, Zhou Z, Amin S, Lee KE, Stork T, Wirth L, Freeman GJ, Alessandrini A, Parangi S. Anti-PD-1/PD-L1 therapy augments lenvatinib's efficacy by favorably altering the immune microenvironment of murine anaplastic thyroid cancer. Int J Cancer 2019;144:2266-78. [PMID: 30515783 DOI: 10.1002/ijc.32041] [Cited by in Crossref: 50] [Cited by in F6Publishing: 53] [Article Influence: 12.5] [Reference Citation Analysis]
61 Benkhelifa S, Rafa H, Belhadef S, Ait-kaci H, Medjeber O, Belkhelfa M, Hetit S, Ait-younes S, De launoit Y, Moralès O, Mahfouf H, Delhem N, Touil-boukoffa C. Aberrant up-regulation of iNOS/NO system is correlated with an increased abundance of Foxp3+ cells and reduced effector/memory cell markers expression during colorectal cancer: immunomodulatory effects of cetuximab combined with chemotherapy. Inflammopharmacol 2019;27:685-700. [DOI: 10.1007/s10787-019-00566-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
62 Laissue P. The forkhead-box family of transcription factors: key molecular players in colorectal cancer pathogenesis. Mol Cancer. 2019;18:5. [PMID: 30621735 DOI: 10.1186/s12943-019-0938-x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 64] [Article Influence: 14.0] [Reference Citation Analysis]
63 Yan L, Liu B. Critical factors in chimeric antigen receptor-modified T-cell (CAR-T) therapy for solid tumors. Onco Targets Ther 2019;12:193-204. [PMID: 30636882 DOI: 10.2147/OTT.S190336] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]
64 Xiang SD, Wilson KL, Goubier A, Heyerick A, Plebanski M. Design of Peptide-Based Nanovaccines Targeting Leading Antigens From Gynecological Cancers to Induce HLA-A2.1 Restricted CD8+ T Cell Responses. Front Immunol 2018;9:2968. [PMID: 30631324 DOI: 10.3389/fimmu.2018.02968] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
65 Tamura R, Tanaka T, Ohara K, Miyake K, Morimoto Y, Yamamoto Y, Kanai R, Akasaki Y, Murayama Y, Tamiya T, Yoshida K, Sasaki H. Persistent restoration to the immunosupportive tumor microenvironment in glioblastoma by bevacizumab. Cancer Sci 2019;110:499-508. [PMID: 30467920 DOI: 10.1111/cas.13889] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 7.4] [Reference Citation Analysis]
66 Navarro-Martín A, Galiana IL, Berenguer Frances MA, Cacicedo J, Cañas Cortés R, Comas Anton S, Padrones Sánchez S, Bolívar Cuevas S, Parry R, Guedea Edo F. Preliminary Study of the Effect of Stereotactic Body Radiotherapy (SBRT) on the Immune System in Lung Cancer Patients Unfit for Surgery: Immunophenotyping Analysis. Int J Mol Sci 2018;19:E3963. [PMID: 30544863 DOI: 10.3390/ijms19123963] [Cited by in Crossref: 22] [Cited by in F6Publishing: 25] [Article Influence: 4.4] [Reference Citation Analysis]
67 Wang W, Xu H, Zhao Z, Zhang G, Lin F. Dynamic and significant changes of T-cell subgroups in breast cancer patients during surgery and chemotherapy. International Immunopharmacology 2018;65:279-83. [DOI: 10.1016/j.intimp.2018.09.039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
68 Englinger B, Pirker C, Heffeter P, Terenzi A, Kowol CR, Keppler BK, Berger W. Metal Drugs and the Anticancer Immune Response. Chem Rev 2019;119:1519-624. [DOI: 10.1021/acs.chemrev.8b00396] [Cited by in Crossref: 171] [Cited by in F6Publishing: 174] [Article Influence: 34.2] [Reference Citation Analysis]
69 Chatterjee G, Pai T, Hardiman T, Avery-Kiejda K, Scott RJ, Spencer J, Pinder SE, Grigoriadis A. Molecular patterns of cancer colonisation in lymph nodes of breast cancer patients. Breast Cancer Res 2018;20:143. [PMID: 30458865 DOI: 10.1186/s13058-018-1070-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
70 Oja AE, Piet B, van der Zwan D, Blaauwgeers H, Mensink M, de Kivit S, Borst J, Nolte MA, van Lier RAW, Stark R, Hombrink P. Functional Heterogeneity of CD4+ Tumor-Infiltrating Lymphocytes With a Resident Memory Phenotype in NSCLC. Front Immunol 2018;9:2654. [PMID: 30505306 DOI: 10.3389/fimmu.2018.02654] [Cited by in Crossref: 56] [Cited by in F6Publishing: 63] [Article Influence: 11.2] [Reference Citation Analysis]
71 Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32:1267-1284. [PMID: 30275043 DOI: 10.1101/gad.314617.118] [Cited by in Crossref: 765] [Cited by in F6Publishing: 829] [Article Influence: 153.0] [Reference Citation Analysis]
72 Gunda V, Gigliotti B, Ndishabandi D, Ashry T, McCarthy M, Zhou Z, Amin S, Freeman GJ, Alessandrini A, Parangi S. Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer. Br J Cancer 2018;119:1223-32. [PMID: 30327563 DOI: 10.1038/s41416-018-0296-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 9.0] [Reference Citation Analysis]
73 Sharabi A, Tsokos MG, Ding Y, Malek TR, Klatzmann D, Tsokos GC. Regulatory T cells in the treatment of disease. Nat Rev Drug Discov 2018;17:823-44. [DOI: 10.1038/nrd.2018.148] [Cited by in Crossref: 170] [Cited by in F6Publishing: 174] [Article Influence: 34.0] [Reference Citation Analysis]
74 Blank A, Roberts DE 2nd, Dawson H, Zlobec I, Lugli A. Tumor Heterogeneity in Primary Colorectal Cancer and Corresponding Metastases. Does the Apple Fall Far From the Tree? Front Med (Lausanne) 2018;5:234. [PMID: 30234115 DOI: 10.3389/fmed.2018.00234] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 7.8] [Reference Citation Analysis]
75 Leman JK, Sandford SK, Rhodes JL, Kemp RA. Multiparametric analysis of colorectal cancer immune responses. World J Gastroenterol 2018; 24(27): 2995-3005 [PMID: 30038466 DOI: 10.3748/wjg.v24.i27.2995] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
76 Kitano S, Nakayama T, Yamashita M. Biomarkers for Immune Checkpoint Inhibitors in Melanoma. Front Oncol 2018;8:270. [PMID: 30073150 DOI: 10.3389/fonc.2018.00270] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 7.6] [Reference Citation Analysis]
77 Schwander S, Keane J. Cause or Effect? The Elusive Role of Regulatory T Cells in Tuberculosis. Am J Respir Crit Care Med 2018;198:11-2. [DOI: 10.1164/rccm.201802-0233ed] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
78 Givechian KB, Wnuk K, Garner C, Benz S, Garban H, Rabizadeh S, Niazi K, Soon-Shiong P. Identification of an immune gene expression signature associated with favorable clinical features in Treg-enriched patient tumor samples. NPJ Genom Med 2018;3:14. [PMID: 29928512 DOI: 10.1038/s41525-018-0054-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
79 Ward-Hartstonge KA, Vasanthakumar A. Regulatory T-cell heterogeneity. Clin Transl Immunology 2018;7:e01012. [PMID: 29610661 DOI: 10.1002/cti2.1012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
80 Menter T, Tzankov A. Mechanisms of Immune Evasion and Immune Modulation by Lymphoma Cells. Front Oncol 2018;8:54. [PMID: 29564225 DOI: 10.3389/fonc.2018.00054] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 9.6] [Reference Citation Analysis]
81 Sacdalan DB, Lucero JA, Sacdalan DL. Prognostic utility of baseline neutrophil-to-lymphocyte ratio in patients receiving immune checkpoint inhibitors: a review and meta-analysis. Onco Targets Ther 2018;11:955-65. [PMID: 29503570 DOI: 10.2147/OTT.S153290] [Cited by in Crossref: 165] [Cited by in F6Publishing: 181] [Article Influence: 33.0] [Reference Citation Analysis]
82 Sadozai H, Gruber T, Hunger RE, Schenk M. Recent Successes and Future Directions in Immunotherapy of Cutaneous Melanoma. Front Immunol 2017;8:1617. [PMID: 29276510 DOI: 10.3389/fimmu.2017.01617] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 5.3] [Reference Citation Analysis]